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Tyk2 Plays a Restricted Role in IFNa Signaling,
Although It Is Required
for IL-12-Mediated T Cell Function
amount of IFNa, although a high concentration of IFNa
can fully transduce its signal even in the absence of
tyk2. Furthermore, IL-12-induced T cell function is de-
fective in these mice. In contrast, these mice respond
normally to IL-6 and IL-10, both of which activate tyk2
Kazuya Shimoda,1,2,11 Kouji Kato,1,2 Kenichi Aoki,1,2
Tadashi Matsuda,5 Akitomo Miyamoto,3,6
Masafumi Shibamori,7 Masakatsu Yamashita,8
Akihiko Numata,1,2 Ken Takase,1,2 Shinji Kobayashi,1,2
Shouichirou Shibata,1,2 Yoshinobu Asano,1,2
Hisashi Gondo,1,2 Kazuo Sekiguchi,7 in vitro. These observations demonstrate that tyk2
plays only a restricted role in mediating IFNa-depen-Keiko Nakayama,4,6 Toshinori Nakayama,8
Takashi Okamura,1,2 Seiichi Okamura,1,2,9 dent signaling while being required in mediating IL-
12-dependent biological responses.Yoshiyuki Niho,1,2,10 and Kei-ichi Nakayama3,4,6
1 Medicine and Biosystemic Science
Kyushu University Graduate School of Medical Introduction
Sciences
3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka Many cytokines bind to their specific cell surface recep-
812-8582 tors and activate members of the Janus family of protein
2 The First Department of Internal Medicine tyrosine kinases (Jaks), which are associated with cyto-
Faculty of Medicine kine receptors (Ihle, 1995). Activated Jaks phosphory-
3 Department of Molecular and Cellular Biology late both cytokine receptors and the Jaks themselves.
Medical Institute of Bioregulation Through recognition of a phosphorylated receptor com-
4 Laboratory of Embryonic and Genetic Engineering plex, signal transducers and activators of transcriptions
Medical Institute of Bioregulation (Stats), which are latent cytoplasmic transcription fac-
Kyushu University tors, are recruited to that complex and are activated by
3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka Jaks (Darnell et al, 1994; Ihle, 1996). Subsequently, these
812-8582 active Stats translocate to the nucleus to affect gene
5 Department of Immunology expression. This Jak-Stat signal pathway is widely used
Faculty of Medicine by members of the cytokine receptor superfamily (Ihle
Toyama Medical and Pharmaceutical University et al., 1995).
2630 Sugitani, Toyama 930-0194 The Jaks were first identified as novel protein tyrosine
6 CREST kinases (Firmbach-Kraft et al., 1990; Wilks et al., 1991),
Japan Science and Technology Corporation (JST) and their function was initially discovered by generating
4-1-8 Honcho, Kawaguchi, Saitama 332-00112 cell lines that were resistant to the effects of interferon
7 Third Institute of New Drug Research (IFN) (Velazquez et al., 1992). Isolation of genomic
Otsuka Pharmaceutical Co., Ltd. clones, capable of reconstituting the response of one
463-10 Kagasuno Kawauchi-cho, Tokushima 771-0192 mutant to IFNa, resulted in the demonstration that tyk2
8 Department of Molecular Immunology is required for IFNa signaling in fibroblasts. Using addi-
Graduate School of Medicine tional IFN response mutant complementation classes,
Chiba University it was shown that cellular responses to IFNa require
1-8-1 Inohana Chuo-ku Chiba, 260-8670 Jak1 and Tyk2, whereas a response to IFNg requires
9 Hematology Department Jak1 and Jak2 (Muller et al., 1993; Watling et al., 1993).
Internal Medicine There are four mammalian Jaks: Jak1, Jak2, Jak3, and
Kyushu Medical Center tyk2. Jak1, Jak2, and tyk2 are ubiquitously expressed,
1-8-1 Chighohama, Cyuou-ku, Fukuoka, Fukuoka whereas the expression of Jak3 appears to be restricted
810-8563 to hematopoietic cells (Witthuhn et al., 1994; Ihle, 1995).
10 Chihaya Hospital They are differentially activated in response to various
2-30-1 Chihaya, Higashi-ku, Fukuoka, Fukuoka cytokines. The essential role of Jaks in mediating cyto-
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transduction via cytokine receptors. Tyk2 is a Janus Jak2-deficient mice show an embryonic lethality due to
kinase, and we developed tyk2-deficient mice to study the absence of definitive erythropoiesis. Jak2-deficient
the requirement for tyk2 in vivo. Tyk2-deficient mice fetal liver myeloid progenitors fail to respond to Epo,
show no overt developmental abnormalities; however, Tpo, and IL-3, while Jak2-deficient fibroblasts fail to
they display a lack of responsiveness to a small respond to IFNg (Neubauer et al., 1998; Parganas et al.,
1998). Jak3-deficient mice show a marked reduction in
the numbers of functional T and B cells (Nosaka et al.,11 To whom correspondence should be addressed (e-mail: kshimoda@
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Figure 1. Targeted Disruption of the Murine
tyk2 Gene
(A) The genomic locus of the wild-type tyk2
gene, the targeting vector, and the disrupted
tyk2 gene. The targeting vector was designed
to replace part of the first coding exon of
the tyk2 protein by the neomycin-resistant
cassette (NeoR). Locations of probes for hy-
bridization of ES cells are indicated. The loca-
tions of restriction sites for EcoRI (R), EcoRV
(V), HindIII (H), XbaI (X), and ClaI (C) are indi-
cated.
(B) Southern blotting analysis of EcoRI-
digested DNA isolated from the tails of mice
derived from the mating of heterozygote
mice. The bands at 6.4 and 3.2 kb correspond
to the endogenous and mutant tyk2 genes,
respectively.
(C) Spleen cells (1 3 108) of each genotype
were lysed and analyzed by immunoprecipi-
tation and Western blotting for tyk2 and Stat1.
In this report, we have focused on the role of tyk2 in mice, as identified by Southern blotting analysis (Figure
1B). Homozygote mice, which displayed no obvious ab-cytokine signaling. Tyk2 is a molecule initially identified
as essential for mediating IFNa signaling, and it is also normalities, were bred at the expected Mendelian fre-
quency. Immunoprecipitation and Western blotting withactivated in response to IL-6 (Stahl et al., 1994), IL-10
(Finbloom and Winestock, 1995), and IL-12 (Bacon et a tyk2 carboxy-terminal polyclonal antibody showed the
presence of 135 kDa tyk2 protein in lysates of spleenal., 1995). In each of these cases, several Jak kinases
including tyk2 are phosphorylated, and additional tyro- cells derived from wild-type mice but not homozygous
mice for the disrupted tyk2 gene, although 91 kDa Stat1sine kinases besides Jaks are also activated. This makes
it difficult to clarify which of the kinases bears unique protein was identified in both wild-type and homozy-
gous mice at comparable levels (Figure 1C). No differ-or redundant roles in cytokine signaling. To assess the
specific and nonredundant role of tyk2, we developed ences were observed with regard to lymphoid, mono-
cyte, or myeloid cell numbers, or the expression of cellmutant mice that are deficient in tyk2 through gene dis-
ruption in embryonic (ES) cells. In contrast to the predic- surface markers, including B220, IgM, CD3, CD4, CD8,
CD14, or Gra-1 (data not shown).tions arising from the analysis of Jak kinase-deficient
mutant cell lines, a high amount of IFNa can transduce
its own signal and biological response in the absence Tyk2 Has Only a Restricted Function and Does
Not Play a Major Role in IFNa Signalingof tyk2, although tyk2 is essential for an antiviral effect
under a low concentration of IFNa. Furthermore, tyk2 Tyk2 was originally cloned as an essential molecule for
IFNa signaling (Velazquez et al., 1992). We therefore firstwas revealed to play an essential role in IL-12-induced
T cell functions. analyzed whether or not tyk2 deficiency affects IFNa
signaling. To assess the role of tyk2 in these responses,
fibroblasts were derived from wild-type and tyk2-defi-Results
cient embryos and examined for their ability to respond
to IFNa. As illustrated in Figure 2, cells from both wild-Generation of tyk2-Deficient Mice
To ablate the tyk2 gene, a targeting construct was de- type and tyk2-deficient embryos respond to IFNa as
assessed by the tyrosine phosphorylation of Jak1, Stat1,signed to replace the first coding exon with a neo resis-
tant gene cassette. It contains a 1.0 kb short arm and and Stat2. In cells from both wild-type and tyk2-deficient
mice, Jak2 is not phosphorylated in response to IFNa,a 8.4 kb long arm of homologous sequences (Figure 1A).
After electroporation and drug selection, five out of 196 whereas it is phosphorylated by the stimulation of IFNg
(Figure 2B). Moreover, IFNa was able to induce IRF-1ES cell clones were identified by PCR and confirmed by
Southern blotting analysis as having undergone suc- gene expression in tyk2-deficient fibroblasts at nearly
equal levels compared to wild-type cells, as illustratedcessful gene targeting. Chimeric mice were bred to ob-
tain germline transmission, and two of these clones gave in Figure 2E. We next examined the level of expression
of cell surface IFNa receptors. Functional IFNa recep-rise to mutant strains. Breeding of heterozygote mice
resulted in wild-type, heterozygote, and homozygote tors are composed of two chains, IFNAR1 and IFNAR2.
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Figure 2. Fibroblasts from tyk2-Deficient
Embryos Respond to IFNa
Embryonic fibroblasts (EF cells) were derived
from either wild-type embryos (1/1) or from
tyk2-deficient embryos (2/2), as described
in Experimental Procedures.
(A) To examine the response to IFNa or IFNg,
EF cells were either not stimulated (-) or were
stimulated with IFNa or IFNg. Following 15
min of stimulation, the cells were harvested
to analyze the induction of tyrosine phos-
phorylation of Jak1 by immunoprecipitation
with anti-Jak1 polyclonal antibody and West-
ern blotting with a monoclonal antibody
against phosphotryrosine (top) or Jak1 poly-
clonal antibody (bottom).
(B) The phosphorylation of Jak2 in response
to IFNa or IFNg was examined.
(C) The phosphorylation of Stat1 was exam-
ined and comparably analyzed with anti-
Stat1 polyclonal antibody.
(D) To examine the phosphorylation of Stat2
in response to IFNa, stimulated or not stimu-
lated cells were lysed. Immunoprecipitation
was carried out with anti-phosphotyrosine
mAb, and Western blotting was performed
with anti-Stat2 polyclonal antibody.
(E) To assess further the ability to respond to
IFNa, the induction of IRF-1 was examined
by Northern blotting 1 hr following the stimu-
lation of EF cells.
(F) To examine the IFNa receptors, cell sur-
face molecules were biotinylated. Cells were
harvested to analyze the expression level of
IFNa receptors by immunoprecipitation with
anti-IFNAR1 or IFNAR2 antibodies and West-
ern blotting with HRP-conjugated biotin (top)
or IFNa receptor antibodies (bottom).
Cell surface proteins were biotinylated using sulfo-NHS- cells from tyk2-deficient mice were unable to respond
to IFNa to induce MHC class I expression under suchbiotin. The cells were harvested to analyze the level of
expression of IFNa receptors by immunoprecipitation a low concentration of IFNa. As an additional assay for
tyk2 function in IFNa signaling, we assessed the abilitywith anti-IFNAR1 or IFNAR2 antibodies and Western
blotting with HRP-conjugated streptoavidin. As illus- of IFNa to protect against the cytopathic effects of vesic-
ular stomatitis virus (VSV). EF cells were treated withtrated in Figure 2F, the level of expression of IFNa recep-
tors (IFNAR1 and IFNAR2) on cells from tyk2-deficient various concentrations of IFNa for 48 hr, removed from
IFNa, and then infected with sufficient VSV to producemice were almost equal to those on cells from wild-type
mice. a 100% cytopathic effect within 24 hr in untreated cells.
EF cells from both wild-type and tyk2-deficient miceIFNa has some biological functions on cells, such as
the induction of the expression of MHC class I antigen responded to IFNg in a dose-dependent manner and
resisted the cytopathic effects of VSV (Figure 3B, b).and of the resistance to viral infections. We monitored
the ability of IFNa to enhance MHC class I expression High concentrations of IFNa (more than 100 U/ml) can
protect both wild-type and tyk2-deficient EF cells. Similaron spleen cells. In contrast to the complete loss of this
function reported in Jak1- or Stat1-deficient mice (Meraz to the result of the induction of MHC class I expression,
a low concentration of IFNa such as 1–10 U/ml had noet al., 1996; Rodig et al., 1998), tyk2-deficient spleno-
cytes exposed to a high concentration of IFNa ex- antiviral effect on EF cells from tyk2-deficient mice, al-
though a small amount of IFNa is enough to protect wild-pressed enhanced levels of MHC class I, comparable
to the level of wild-type spleen cells (Figure 3A). When type EF cells from VSV infection (Figure 3B, a).
spleen cells were treated with a low concentration of
IFNa, such as 10 U/ml, those derived from wild-type The Absence of tyk2 Does Not Affect IL-6
or IL-10 Signalingmice showed an enhancement of MHC class I expres-
sion, which was slightly less than that seen when cells In addition to IFNa, tyk2 activation is observed in re-
sponse to IL-6 and IL-10.were treated with 1000 U/ml of IFNa, although spleen
Immunity
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Figure 3. Biological Response to IFNa
(A) MHC class I induction in spleen cells.
Spleen cells from wild-type or tyk2-deficient
mice were stimulated with PBS (dot line) or
the indicated concentration of IFNa (solid
line) for 72 hr and analyzed for the expression
of MHC class I by flow cytometry.
(B) Antiviral response of fibroblasts. Primary
EF cells from wild-type or tyk2-deficient mice
were stimulated with IFNa (a) or IFNg (b) and
cultured with vesicular stomatitis virus. After
48 hr, surviving cells were quantified by vital
dye staining.
IL-6 has been shown to cause an activation of Jak1, observations indicate that tyk2 has no obligatory role
to play in IL-10 signaling.Jak2, and tyk2 (Stahl et al., 1994). Previous studies with
mutant cell lines have suggested that the presence of
Jak1 is critical for IL-6 signaling (Guschin et al., 1995). Tyk2 Is Essential for IL-12-Mediated T Cell Response
IL-12 is important in the control of cell-mediated immu-Moreover, from an analysis of Jak1- and Jak2-deficient
mice, Jak1 but not Jak2 was demonstrated to play a nity and induces tyrosine phosphorylation of Jak2 and
tyk2 (Bacon et al., 1995). Since Stat4 is only tyrosinecritical role in IL-6 signaling (Parganas et al., 1998; Rodig
et al., 1998). Consistent with these observations, EF cells phosphorylated following the stimulation of T cells with
IL-12 (Jacobson et al., 1995), we assessed the abilityfrom both wild-type and tyk2-deficient mice respond to
IL-6 as assessed by tyrosine phosphorylation of Stat1 of tyrosine phosphorylation of Stat4 in tyk2-deficient T
cells. IL-12 activates Stat4 in spleen cells from wild-typeand Stat3 (Figure 4A, top). Furthermore, thymocytes
from tyk2-deficient mice proliferate in the stimulation mice. In contrast, Stat4 activation was decreased but
still detectable in tyk2-deficient cells stimulated with IL-with IL-6 and PHA at levels comparable to wild-type
mice (Figure 4B, left), indicating that tyk2 is either not 12 (Figure 5A). To determine whether this decrease of
Stat4 activation by IL-12 in tyk2-deficient mice is or isrequired or else is redundant in IL-6 signaling.
IL-10 affects both monocytes and T cells by the activa- not due to the alteration of IL-12 receptor expression,
we examined the level of expression of IL-12 receptortion of Jak1 and tyk2. It has been shown that monocytes
from Jak1-deficient embryos did not respond to IL-10 b1 chain on cells from tyk2-deficient mice. As shown in
Figure 5B, the levels of expression of IL-12 receptor b1by inhibiting LPS-induced TNFa production, thus sug-
gesting that Jak1 plays an obligatory role in mediating chain on spleen cells are almost equal between wild-
type and tyk2-deficient mice. Since tyk2-deficient cellsIL-10 signaling (Rodig et al., 1998). We assessed
whether tyk2 is also essential for the response to IL-10. displayed only a limited capacity to activate Stat4
through IL-12 stimulation, we examined whether partialIL-10 stimulates tyrosine phosphorylation of Stat3 in
CD32 spleen cells derived from wild-type mice, and the signaling was of sufficient magnitude to induce biologi-
cal responses in the treated cells. Stat4-deficient micephosphorylation of Stat3 by IL-10 is also observed in
CD32 spleen cells from tyk2-deficient mice (Figure 4A, showed that Stat4 bears all IL12 functions, including
mitogenesis, induction of IFNg from T cells, enhance-bottom). As shown in Figure 4B (right), there is no differ-
ence in proliferation between T cells from wild-type mice ment of natural killer cytolytic function, and Th1 differen-
tiation (Kaplan et al., 1996; Thierfelder et al., 1996).and T cells from tyk2-deficient mice induced by a combi-
nation of IL-2 and IL-10. In addition, the upregulation of To examine whether tyk2 is required for IL-12-induced
proliferation, T lymphocytes were activated with anti-MHC class II antigens induced by IL-10 is also observed
in cells from tyk2-deficient mice (Figure 4C). Further- CD3 for 4 days, washed, and then stimulated with IL-
12 for an additional 48 hr. IL-12 stimulation of activatedmore, macrophages derived from tyk2-deficient mice,
as well as cells from wild-type mice, respond to IL-10 lymphocytes from both wild-type and tyk2-deficient
mice leads to an equal level of increase in proliferationin a dose-dependent manner by inhibiting LPS and IFNg-
induced TNFa production (Figure 4D). In contrast to (Figure 5C).
One major activity of IL-12, in synergy with CD3 orthe absence of a low dose-IFNa-inducible biological
response in tyk2-deficient cells, a low dose of IL-10 has IL-2, is the induction of IFNg by resting and activated
NK and T cells. We therefore examined the ability ofan inhibitory effect on tyk2-deficient macrophages, as
well as on macrophages from wild-type mice. These splenocytes from wild-type and tyk2-deficient mice to
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Figure 4. The Absence of tyk2 Does Not Af-
fect IL-6 or IL-10 Signaling
(A) Stat3 phosphorylation in tyk2-deficient EF
cells by IL-6 (top) or IL-10 (bottom). To exam-
ine the response to IL-6, EF cells were either
not stimulated (2) or else were stimulated
with a mixture of IL-6 and soluble IL-6 recep-
tor for 15 min. To examine the response to
IL-10, CD32 spleen cells derived from wild-
type or tyk2-deficient mice were cultured with
PHA (2 mg/ml) for 72 hr, starved for 12 hr, and
stimulated with or without IL-10 (50 ng/ml) for
15 min. The cells were harvested to analyze
the induction of tyrosine phosphorylation of
Stat by immunoprecipitation with anti-Stat3
polyclonal antibody and Western blotting
with a monoclonal antibody against phos-
photyrosine or Stat3 polyclonal antibody.
(B) T cell proliferation by IL-6 or IL-10. Thymo-
cytes from wild-type and tyk2-deficient mice
were cultured for 96 hr with PHA (10 mg/ml)
and IL-6 (10 ng/ml) (left) or with IL-10 (10 ng/
ml) and 1000 U/ml of IL-2 (right), and the cells
were labeled with tritiated thymidine. In each
case, the extent of incorporation relative to only
PHA stimulation control (for IL-6-induced
proliferation) or IL-2 stimulation control (for
IL-10-induced proliferation) is plotted as the
stimulation index.
(C) MHC class II antigen expression on CD32
spleen cells. CD32 spleen cells were obtained
by negative selection using magnetic beads
from wild-type or tyk2-deficient mice. Cells
were stimulated with PBS or IL-10 (10 ng/ml)
for 24 hr and analyzed for the expression of
MHC class II by flow cytometry.
(D) Inhibition of LPS-induced TNF production
by IL-10. Macrophages (1 3 105) from wild-
type and tyk2-deficient mice were incubated
with IL-10 for 12 hr followed by treatment with
LPS (10 ng/ml) and IFNg (100 U/ml). After 48
hr, TNF in the culture supernatants was quan-
tified by ELISA.
produce IFNg. Strikingly, the stimulation of spleen cells reduction in IFNg production from tyk2-deficient T cells
by IL-12 occurs at the transcriptional level, we analyzedfrom tyk2-deficient mice with IL-12 resulted in no detect-
able IFNg production, whereas IFNg was readily de- the expression of IFNg mRNA by the stimulation of IL-2
and IL-12 in spleen cells from wild-type and tyk2-defi-tected in the supernatants of IL-12-stimulated spleno-
cytes from wild-type mice (Figure 6A). Spleen cells cient mice (Figure 6C). IFNg mRNA was only detected
in spleen cells from wild-type mice by the stimulationcontain T cells and NK cells, both of which can produce
IFNg by IL-12 stimulation. We then examined the num- of IL-2 plus IL-12 and not detected in those from tyk2-
deficient mice. Then, the reduction in IFNg productionbers of T cells and NK cells in the spleen. The population
of CD3-positive T cells is 42% in wild-type mice and from tyk2-deficient T cells by IL-12 is thought to occur
at the transcriptional level as a consequence of the re-44.5% in tyk2-deficient mice, while the population of
NK cells is 3.1% in wild-type mice and 3.0% in tyk2- duction in Stat4 activation by IL-12.
The defect in IFNg production by IL-12 stimulationdeficient mice. Since there is no difference in T and NK
cell numbers of spleen cells from wild-type and tyk2- was observed under the costimulation with anti-CD3 or
IL-2. Anti-CD3 stimulation of T cells produces IL-2. Then,deficient mice, we isolated T cells to examine the ability
of producing IFNg in response to IL-12. we examined whether the activation of Stat5 by IL-2
stimulation was affected on spleen cells from tyk2-defi-As shown in Figure 6B, small amounts of IFNg were
produced by CD3-negative cells (those that contain NK cient mice. As illustrated in Figure 6D, IL-2 stimulated
tyrosine phosphorylation of Stat5 in spleen cells fromcells and B cells) from wild-type mice, while CD3-nega-
tive cells from tyk2-deficient mice did not produce IFNg both wild-type and tyk2-deficient mice. Then, the defect
in IFNg production under the stimulation of anti-CD3by the stimulation of IL-2 plus IL-12. On the other hand,
large amounts of IFNg were produced from CD3-positive plus IL-12 or IL-2 plus IL-12 is thought to be due to the
abolishment of IL-12 signaling.T cells from wild-type mice, whereas T cells from tyk2-
deficient mice with IL-2 and IL-12 resulted in no detect- IL-12 facilitates the differentiation of naive CD41 cells
into Th1 cells that secrete IFNg after antigen stimulation.able IFNg production. To determine whether or not the
Immunity
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Figure 5. IL-12 Signaling in tyk2-Deficient
Mice
(A) IL-12-induced Stat4 phosphorylation in
spleen cells from tyk2-deficient mice was al-
most completely abolished, although it re-
mained detectable. Spleen cells from wild-
type and tyk2-deficient mice were cultured
with 500 U/ml of IL-2 for 72 hr, starved for 12
hr, and stimulated with or without IL-12 (20
ng/ml) for 15 min and lysed. Stat4 was immu-
noprecipitated and analyzed by Western blot-
ting with a monoclonal antibody against
phosphotyrosine.
(B) Equal level of expression of IL-12 receptor
on spleen cells from tyk2-deficient mice. To
examine the level of expression of cell surface
IL-12 receptor, biotinylated spleen cells from
wild-type or tyk2-deficient mice were lysed,
and immunoprecipitation with IL-12 receptor
b1 chain antibody was carried out. Cell sur-
face IL-12 receptor b1 chain was analyzed by
Western blotting with HRP-conjugated strep-
tavidin.
(C) Normal mitogenetic response of activated lymphocytes from tyk2-deficient mice. CD31 splenic lymphocytes were obtained by the immuno-
magnetic cell isolation method. Cells were cultured for 72 hr in the presence of anti-CD3. Cells were washed and cultured with or without IL-
12 (7 ng/ml) for 24 hr, and the cells were labeled with tritiated thymidine for a further 24 hr.
This activity requires Stat4 because T cells from Stat4- cording to an analysis of Stat1-deficient mice, it has
been shown that Stat1 plays an essential role in mediat-deficient mice fail to differentiate into Th1 cells (Kaplan
et al., 1996; Thierfelder et al., 1996). We therefore used ing IFN-dependent biological responses (Durbin et al.,
1996; Meraz et al., 1996).an in vitro assay to assess the consequence of tyk2
deletion on helper T cell differentiation. Enriched splenic Previous studies using mutant human fibroblast cell
lines that are deficient in Jak1, Jak2, or tyk2 have shednaive CD41 cells were cultured for 2 days with immobi-
lized anti-TCR in the presence of IL-12 and anti-IL4 to light on IFN signaling (Muller et al., 1993, Watling et
al., 1993). Cell lines deficient in Jak1 are incapable ofpromote Th1 differentiation or in the presence of IL-4 to
promote Th2 differentiation. The cells were then cultured mediating IFNa and IFNg, while those deficient in tyk2
(U1D cells) are incapable of mediating IFNa, and thosewith only cytokines for another 3 days. As illustrated in
Figure 7A, IFNg-producing Th1 cells were generated deficient in Jak2 are incapable of responding to IFNg.
These observations demonstrate the reciprocal interde-from naive CD41 cells from wild-type mice in the condi-
tions that promote Th1 differentiation. In contrast, the pendence between Jak1 and tyk2 activities in the IFNa
pathway and between Jak1 and Jak2 activities in thegeneration of Th1 cells in the Th1-skewed conditions
was not dramatically enhanced from naive CD41 cells IFNg pathway. They suggest that Jak1 and tyk2 or Jak1
and Jak2 would make a correct assembly of IFN receptorfrom tyk2-deficient mice. In cultures supporting Th2 dif-
ferentiation, restimulation resulted in the generation of complexes and may be juxtaposed on receptor dimer-
ization and cross-phosphorylate in response to IFNIL-4-producing Th2 cells, and there was no difference
between wild-type and tyk2-deficient mice. treatment.
Consistent with this hypothesis, cells from Jak1-defi-Our results demonstrate that tyk2 is critical for mediat-
ing IL-12-induced IFNg production from T cells and the cient mice failed to respond to IFNa or IFNg and lost all
IFN-inducible biological activities (Rodig et al., 1998).differentiation into Th1 cells from naive helper T cells,
although it does play a redundant role in T cell prolifera- Fibroblasts from Jak2-deficient embryos failed to re-
spond to IFNg for the phosphorylation of Jak1 or Stat1tion by IL-12.
or the induction of IRF-1 (Parganas et al., 1998). Further-
more, cells from Jak2-deficient embryos were not pro-Discussion
tected against EMCV infection under a high concentra-
tion of IFNg. Therefore, it was clearly demonstrated thatTyk2 was originally cloned as an essential molecule for
the transduction of IFNa signaling (Velazquez et al., Jak1 and Jak2 are both independently required for the
biological responses mediated by IFNg.1992). When cells are treated with IFNa, Jak1 and tyk2
are initially phosphorylated, followed by Stat1 and Stat2 For IFNa signaling, the story is a little bit different. As
shown in Figure 2A, Jak1 is phosphorylated by IFNa inactivation. The activated Stat1 and Stat2 form ISGF-3
(IFN-stimulated gene factor 3) complexes and bind to EF cells from tyk2-deficient embryos. In addition, the
tyrosine phosphorylation of Stat1 and Stat2 and thethe ISRE (IFN stimulated response element) of the IFNa
inducible gene. On the other hand, Jak1 and Jak2 are induction of the IRF-1 gene are also observed in EF cells
from tyk2-deficient mice in response to IFNa (Figuresphosphorylated in response to IFNg, followed by the
activation of Stat1, which binds to the GAS sites (gamma 2C–2E). Regarding the biological responses induced by
IFNa, a high concentration of IFNa showed antiviral ef-activated sites) of the IFNg inducible gene by making
Stat1 homodimerizations (Darnell et al., 1994). Ac- fects and the induction of MHC class I antigen on fibro-
Tyk2 Kinase Mediates IL-12 Functions
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Figure 6. Lack of IL-12-Induced T Cell Func-
tions in tyk2-Deficient Mice
(A) Lack of IFNg production following IL-12
stimulation of splenocytes from tyk2-defi-
cient mice. Splenocytes were obtained from
either wild-type or tyk2-deficient mice and
plated in wells containing anti-CD-3 (10 mg/
ml) or IL-2 (50 U/ml), either alone or with the
addition of the indicated amount of IL-12. Su-
pernatants were collected after 48 hr, and the
amount of IFNg was quantified by ELISA.
(B) Lack of IFNg production from T cells in
response to IL-12 from tyk2-deficient mice.
CD31 cells and CD32 cells from nonadherent
splenocytes were stimulated with IL-2 only
or with IL-2 plus IL-12. Supernatants were
collected after 48 hr, and the amount of IFNg
was quantified by ELISA.
(C) Decreased levels of expression of IFNg
mRNA in splenocytes by IL-12 stimulation
from tyk2-deficient mice. Splenocytes from
wild-type or tyk2-deficient mice were stimu-
lated with IL-2 only or IL-2 plus IL-12 for 20
hr. The induction of IFNg mRNA was exam-
ined by Northern blotting.
(D) IL-2-induced Stat5 phosphorylation in
spleen cells from tyk2-deficient mice was not
affected. Spleen cells from wild-type and
tyk2-deficient mice were stimulated with or
without IL-2 (1000 U/ml) for 15 min and lysed.
Stat5 was immunoprecipitated and analyzed
by Western blotting with a monoclonal anti-
body against phosphotyrosine.
blasts and spleen cells from tyk2-deficient cells, as well cells from tyk2-deficient mice, the reduction in IFNa
signaling at low concentrations may be due to eventsas cells from wild-type mice. This means that tyk2 is not
essential for mediating IFNa signaling, and the biological that occurred after IFNa binds to its receptors. Takaoka
recently reported the presence of cross-talk betweenfunctions induced by IFNa are transduced by means of
Jak1 only. IFNg and IFNa signaling components (Takaoka et al.,
2000). This cross-talk is unidirectional in that IFNg sig-Our finding is in contrast to the previous conception
that Jak1 and tyk2 are reciprocally independent in the naling was dependent on IFNa signaling, while IFNa
signaling was not affected by IFNg signaling. ConsistentIFNa pathway (Muller et al., 1993) and suggests the
importance of Jak1 in IFNa signaling. Since it is reported with this, Jak2, which is an essential molecule for the
IFNg signaling, is not involved in the stimulation of IFNathat tyk2 is required for the correct formation of the
IFNa receptor and that the number of high-affinity IFNa in cells that are deficient in tyk2, and so IFNa signaling
is transduced by means of Jak1 only (Figure 2B). Sincebinding sites on U1D cells (tyk2-deficient human fibro-
blasts) is markedly decreased (Pellegrini et al., 1989), cells from Jak1-deficient mice could not respond to IFNa
completely under high concentrations (Rodig et al.,this may be the reason why U1D cells could not respond
to IFNa. In contrast to U1D cells, the expression levels 1998), our findings suggest two possibilities. One is that
only Jak1 phosphorylates Stat1, while tyk2 is unable toof IFNa receptors (IFNAR1 and IFNAR2) on cells from
tyk2-deficient mice were comparable to those on cells directly activate Stat1, although the binding of IFNa to
its cell surface receptor activates both Jak1 and tyk2.from wild-type mice (Figure 2F).
Under stimulation by a low concentration of IFNa, In this situation, the role of tyk2 is probably to activate
Jak1 for the augmentation of Jak1 function in IFNa sig-such as 1–10 U/ml, tyk2-deficient EF cells or spleno-
cytes could not respond to IFNa to show any antiviral naling. The other is that when IFNa binds to its receptor,
Jak1 is phosphorylated. After this, the phosphorylatedeffect or the induction of HLA class I antigen, respec-
tively. However, such a low concentration of IFNa is Jak1 activates tyk2. Finally, both activated Jak kinases
phosphorylate Stat1. The latter could explain our obser-enough for the cells from wild-type mice to mediate
the above IFNa-inducible biological activities. Since the vation that there is a difference between wild-type and
tyk2-deficient cells regarding the antiviral effect and theexpression levels of IFNa receptors are not affected on
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Figure 7. In Vitro T Helper Cell Differentiation
(A) Naive CD4 T cells from wild-type and tyk2-
deficient mice were stimulated with immobi-
lized anti-TCR mAb plus IL-12 and anti-IL-4
(Th1-skewed). The cultured cells were sub-
jected to intracellular staining with anti-IFNg
and anti-IL-4. The numbers of the cells har-
vested (yield) are almost same among experi-
ments. The percentage of the cells in each
quadrant are shown as boxed numbers.
(B) Naive CD4 T cells from wild-type and tyk2-
deficient mice were stimulated with immobi-
lized anti-TCR mAb plus IL-4 (Th2-skewed).
induction of the HLA-class I antigen expression in the role in the IL-10-signaling pathway (Rodig et al., 1998).
We assessed whether tyk2 is also essential for the re-presence of only a small amount of IFNa.
In the IL-6- and IL-10-signaling pathway, it has been sponse to IL-10. All examined IL-10 functions, including
Stat3 phosphorylation, T cell proliferation, induction ofreported that Jak1 plays an essential role in promoting
biological responses (Rodig et al., 1998). The IL-6 family MHC class II antigen, and the inhibition of LPS and IFNg-
induced TNF production, are conserved in cells fromof cytokines utilizes a common signaling chain, gp130,
that activates several of the Jak family members, includ- tyk2-deficient mice. Cells derived from tyk2-deficient
mice do not respond to low-dose IFNa and thus do noting Jak1, Jak2, and tyk2 (Stahl et al., 1994). Previous
studies using mutant cell lines that are deficient in Jak1, show the induction of the MHC class I antigen or an
antiviral effect. In contrast to this IFNa-signaling path-Jak2, or tyk2 suggested that the absence of Jak2 or
tyk2 did not affect gp130 function, except in the absence way, a low dose of IL-10 has the same effect on macro-
phages from tyk2-deficient mice, as well as cells fromof Jak1 (Guschin et al., 1995). An analysis of Jak1-defi-
cient and Jak2-deficient mice revealed an essential role wild-type mice, indicating that tyk2 does not have an
obligatory role to play in IL-10 signaling.of Jak1, but not of Jak2, in IL-6-promoting biological
responses (Parganas et al., 1998; Rodig et al., 1998). IL-12 is a cytokine that controls cell-mediated immu-
nity, including the induction of IFNg from T and NK cells,The absence of tyk2 does not affect the phosphorylation
of Stat3 or the proliferation of thymocytes by IL-6, con- the stimulation of T cell proliferation as a costimulant,
the enhancement of cytolytic activity of T and NK cells,sistent with the observation in Jak2-deficient mice, indi-
cating the redundant role of tyk2 in IL-6 signaling. IL- and the differentiation of Th1 cells from progenitors. IL-
12 induces the tyrosine phosphorylation of Jak2 and10 acts on macrophages to inhibit the production of
reactive intermediates and results in the inhibition of tyk2, followed by that of Stat4. Since Stat4-deficient
mice were reported to be deficient in all the IL-12 biologi-cytokine synthesis by activated Th1 T cells and natural
killer cells. The stimulation of cells with IL-10 induces cal activities, Stat4 is thought to bear all IL-12 functions.
In tyk2-deficient cells (Figure 5A), the phosphorylationthe activation of Jak1 and tyk2. Since it has been re-
ported that macrophages derived from Jak1-deficient of Stat4 by IL-12 was decreased. This was not due to the
decrease in IL-12 receptor expression levels, becausemice do not respond to IL-10 by inhibiting LPS-induced
TNFa production, Jak1 is thought to play an essential there is no difference between wild-type and tyk2-defi-
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cient mice in the expression levels of IL-12 receptor naling pathway. Moreover, tyk2 was revealed to play an
b1 chain detected by Western blotting (Figure 5B). In essential role in IL-12-induced T cell functions.
addition, a deficiency in tyk2 greatly inhibited the IFNg
Experimental Proceduresproduction from T cells (Figure 6B). Although the pro-
duction of IFNg from T cells induced by IL-12 requires
Targeting Vector
costimulation with anti-CD3 or IL-2, the phosphorylation Genomic clones containing portions of the murine tyk2 gene were
of Stat5, which is a major stat protein activated by IL-2, isolated from a Lambda Fx II murine 129/Sv genomic library (Stra-
in response to IL-2 is not affected in the absence of tyk2 tagene). To generate the tyk2-targeting vector, a 4.2 kb XbaI-EcoRV
fragment containing exon 1 was replaced with a neomycin-resistant(Figure 6D). Then, the defect in IFNg production under
cassette. A herpes simplex thymidine kinase (HSV-tk) cassette thatthe stimulation of anti-CD3 plus IL-12 or IL-2 plus IL-12
mediated negative selection was inserted in the 39-end of the tyk2-is thought to be due to the abolishment of IL-12 signal-
neo construct.ing. IFNg mRNA was only detected in spleen cells from
wild-type mice by the stimulation of IL-2 plus IL-12 and Transfection of ES Cells and Generation of tyk2-Deficient Mice
not detected in those from tyk2-deficient mice (Figure E14 (129/Ola mouse strain) ES cells were cultured in Dulbecco’s
6C). Then the reduction of IFNg production from tyk2- modified Eagle medium (DMEM) containing 15% FCS (Hyclone), 1
mM sodium pyruvate, 2 mM L-glutamine, 0.1 mM nonessentialdeficient T cells by IL-12 occurred at the transcriptional
amino acid, 50 mM 2-mercaptoethanol, 100 U/ml of Penicillin-G, 100level as a consequence of the reduction of Stat4 activa-
mg/ml of streptomycin, and 1000 U/ml LIF (all obtained from GIBCO-tion by IL-12.
BRL, with the exception of FCS). Irradiated primary embryonic fibro-Th1 and Th2 helper T cells play unique roles in immune blasts expressing the neomycin-resistant gene were used as feeder
responses. IL-12 facilitates differentiation of naive CD41 cells for ES cells. Eighty micrograms of NotI-linearized tyk2 plasmid
cells into Th1 cells, the process of which is regulated construct was electroporated into the 4 3 107 ES cells using a
gene pulser set at 0.3 kV, 125 mF (BioRad). Selection 24 hr afterby Stat4. As shown in Figure 7A, CD41 splenic helper
electroporation was in 300 mg/ml geneticin (G418)(GIBCO-BRL) andT cells from tyk2-deficient mice failed to differentiate to
1 mM gancyclovir. ES clones were picked up and expanded 7–10IFNg-producing-Th1 cells.
days after electroporation. Five positive clones were identified byOur observations demonstrate that tyk2 plays a major
PCR, confirmed by Southern blotting, and microinjected into blasto-
role in the phosphorylation of Stat4, and the absence cysts. Two clones gave germline transmission.
of tyk2 reduces Stat4 activation, resulting in the loss of
IL-12 biological responses, such as IFNg production Genotyping by Southern Blotting and PCR
For PCR screening, the following primers were used: gtyk2F1from T cells and the differentiation to Th1 cells from
(59-CAAGCACTGAGCTACAGCCTATTC-39) annealing upstream of thenaive helper T cells, although we cannot deny the possi-
targeting construct and PJL (59-TGCTAAAGCGCATGCTCCAGbility that other molecules, which might also be essential
ACTG-39) annealing in the neomycin-resistant cassette. Southernfor IL-12 signaling, just as Stat4 is, are affected by the
blotting analysis was performed on 20 mg of EcoRI-digested geno-
absence of tyk2. The presence of Jak2 does not com- mic DNA. Filters were probed with a 32P-labeled external probe.
pensate for this tyk2 function. On the other hand, T
cell proliferation induced by IL-12 is not affected by a Tyk2 Western Blotting
Spleen cells from wild-type or tyk2-deficient mice were lysed in lysisdeficiency in tyk2. Since it is also regulated by Stat4, a
buffer as previouly described (Shimoda et al., 1997). Cell lysatesvery small amount of activated Stat4 that is observed
were centrifuged at 12,000 3 g for 15 min to remove debris, andin tyk2-deficient cells may be of sufficient magnitude to
the supernatants were incubated with anti-tyk2 polyclonal antibodyinduce the proliferation response in treated cells. and anti-Stat1 polyclonal antibody (Santa-Cruz) overnight. Immune
The Jak family of protein tyrosine kinases consists complexes were precipitated with protein A-Sepharose, washed
of four members (Jak1, Jak2, Jak3, and tyk2) that are three times in lysis buffer, and then eluted with sample buffer for
differentially activated in response to various cytokines SDS-PAGE. Eluted proteins were resolved by SDS-10% PAGE and
transferred to a nitrocellulose membrane. Membranes were probed(Ihle, 1995). Deficiency in Jak1 results in perinatal lethal-
using anti-tyk2 and anti-Stat1 antibodies and visualized with theity and impaired lymphocytic development. Jak1-defi-
ECL detection system (Amersham).cient cells fail to manifest biological responses to cyto-
kines that bind to three distinct families of cytokine
Preparation of Fractionated Spleen Cells
receptors, all class II cytokine receptors, cytokine recep- CD31 and CD32 spleen cells derived from wild-type and tyk2-defi-
tors that utilize the common g chain, and gp130 (Rodig, cient mice were obtained by the immunomagnetic cell isolation
1998). Jak2 deficiency causes an embryonic lethality method using Dynabeads coated with a rat mAb specific for each
mouse cell surface antigen (Dynal). Spleen cells were cultured ondue to the absence of definitive erythropoiesis, and fetal
plastic plates for 1 hr at 378C to remove macrophages. Nonadherentliver myeloid progenitors fail to respond to Epo, IL-3,
spleen cells were incubated with Dynabeads mouse CD3 for 20 minand TPO, while Jak2-deficient fibroblasts fail to respond
at 48C with gentle rotation. The rosetted CD31 cells were collectedto IFNg (Neubauer et al., 1998; Parganas et al., 1998).
by placing the test tube containing cells in Dynal MPC for 2 min.
Mutant mice lacking Jak3 had a phenotype of severe Unrosetted cells in the culture with Dynabeads mouse CD3 were
combined immunodeficiency and functional deficiency also used as CD32 cells.
of mature T and B cells, indicating a nonredundant role
Biotinylation of Cell Surface Proteinsfor Jak3 in the function of all the receptors utilizing the
Cell surface molecules were biotinylated by the incubation of Sulfo-common g chain. Here, we report the phenotype of tyk2-
NHS-biotin (Pierce) with cells in PBS (pH 8.0) for 30 min at roomdeficient mice. In contrast to the other Jak kinases, the
temperature according to the directions of the manufacturer.absence of tyk2 does not affect cell proliferation regard-
less of the cell lineage. In spite of previous speculation Immunoprecipitation, SDS-PAGE, and Western Blotting
that tyk2 is an essential molecule in IFNa signaling, tyk2 Embryonic fibroblasts from wild-type or tyk2-deficient embryos
was revealed to be a redundant molecule that mediates were cultured in DMEM supplemented with 10% fetal bovine serum.
The cells were starved for 12–14 hr in serum-free DMEM prior tothe IFNa response, although it modulates the IFNa sig-
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cytokine stimulation. Spleen cells from wild-type or tyk2-deficient Th1/2 Cell Differentiation In Vitro
Naive (CD44low) CD4 T cells from the spleen were prepared by pan-mice were cultured with 25 mg/ml of LPS for 24 hr or 2 mg/ml of
PHA for 72 hr. Prior to cytokine stimulation, cells were washed in ning with anti-CD8 and anti-CD44 mAbs. The enriched naive CD4
T cells (5 3 105) were stimulated for 2 days with immobilized anti-TCRPBS and allowed to sit for 24 hr in RPMI with 2% FCS. The cells
were treated with IFNa (1000 U/ml), IFNg (100 ng/ml), IL-6 (500 ng/ in the presence of IL-12 and anti-IL-4 mAb (Th1-skewed condition) or
IL-4 (Th2-skewed condition). The cells were then cultured with onlyml) plus soluble IL-6 receptor (500 ng/ml), IL-10 (50 ng/ml), or IL-12
(20 ng/ml) for 15 min, and lysed in lysis buffer as previously de- cytokines for another 3 days. Intracellular staining of IFNg and IL-4
was performed as described (Yamashita et al., 1999).scribed (Shimoda et al., 1997). The supernatants were incubated
with the indicated antibodies for 12 hr. Immune complexes were
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